With the analysis among 1,745 patents, we discovered top 435 key players by total patent application. Immatics Biotechnologies GmbH, Amgen, Inc., National Cancer Center Korea are dominant in this area. They take 12.61% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 102
California, United States
Patent: 79
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 39
Basel-Stadt, Switzerland
Patent: 33
California, United States
Patent: 33
Precision Biologics, Inc.
Texas, United States
Patent: 31
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 30
Tokyo-to, Japan
Patent: 28
Vertex Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 28
Indiana, United States
Patent: 26
With the analysis among 68 patents, we discovered top 19 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Combined Therapeutics, Inc., Enliven Therapeutics, Inc. /US/ are active in this area.
Institut National de la Santé et de la Recherche Médicale
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 11
Enliven Therapeutics, Inc. /US/
Colorado, United States
Patent: 4
Saskatchewan, Canada
Patent: 4
California, United States
Patent: 3
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 2
LISCure Bioscience Co. Ltd.
Sumitomo Dainippon Pharma Oncology, Inc.
Biosplice Therapeutics, Inc.
California, United States
Patent: 1
With the analysis among related 1,514 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Amgen, Inc., Immatics Biotechnologies GmbH, Institut National de la Santé et de la Recherche Médicale take 9.71% of patent filing during this period.
California, United States
Patent: 65
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 54
Institut National de la Santé et de la Recherche Médicale
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 25
Zhejiang Sheng, China
Patent: 17
Centre National De La Recherche Scientif
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 16
Yonsei Industry-Academic Cooperation Foundation
Shanghai Shi, China
Patent: 14
With the analysis among related 1,514 patents in last 5 years, we discover 380 new entrants. Institut National de la Santé et de la Recherche Médicale, Remedy Plan, Inc., Inventisbio Shanghai Ltd are the most active new entrants in this area.
Institut National de la Santé et de la Recherche Médicale
Shanghai Shi, China
Patent: 14
Combined Therapeutics, Inc.
Massachusetts, United States
Patent: 11
The Salk Institute for Biological Studies
California, United States
Patent: 11
Henan Sheng, China
Patent: 10
Université d'Aix-Marseille
Washington, United States
Patent: 9
Institut Jean Paoli & Irene Calmettes
Lanzhou Institute of Chemical Physics
Gansu Sheng, China
Patent: 8
With the analysis among 777 patents, we discovered top 186 universities and scientific research institutions by total patent application. Shenyang Pharmaceutical University, Zhejiang University, Fudan University are dominant in this area. They take 9.91% of the total patent filing.
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 28
Zhejiang Sheng, China
Patent: 21
Shanghai Shi, China
Patent: 16
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 14
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 12
Tokyo-to, Japan
Patent: 12
Gansu Sheng, China
Patent: 11
The Salk Institute for Biological Studies
California, United States
Patent: 11
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 11
Henan Sheng, China
Patent: 10